Clinical Trials Directory

Trials / Completed

CompletedNCT00013728

Asthma & Exposure to Peaks in Particulate Air Pollution

Status
Completed
Phase
Study type
Observational
Enrollment
24 (planned)
Sponsor
National Institute of Environmental Health Sciences (NIEHS) · NIH
Sex
All
Age
9 Years – 18 Years
Healthy volunteers
Not accepted

Summary

We are testing the following two hypotheses: 1) Peaks in hourly exposures to airborne particulate matter (PM) of outdoor origin will be more closely associated with acute asthmatic responses to particles than 24-hour average exposures in susceptible individuals; 2) Personal exposure to PM, and estimated particle dose to the lungs, will be more closely associated with daily asthma severity than standard outdoor particle concentrations measured as 24-hour averages at governmental monitoring sites.

Detailed description

We are testing the following two hypotheses: 1) Peaks in hourly exposures to airborne particulate matter (PM) of outdoor origin will be more closely associated with acute asthmatic responses to particles than 24-hour average exposures in susceptible individuals; 2) Personal exposure to PM, and estimated particle dose to the lungs, will be more closely associated with daily asthma severity than standard outdoor particle concentrations measured as 24-hour averages at governmental monitoring sites. Toxicological data for asthma exacerbations from particulate matter (PM) suggests that particle deposition in the lower respiratory tract can cause inflammatory and lung function changes suggestive of asthma pathology. There is now a scientific need to explain epidemiological findings of ambient PM effects on asthmatics at mass concentrations below what is expected (from toxicological data) to be harmful. One possibility is that study participants are encountering unmeasured short-term excursions of particle mass levels capable of inducing adverse reactions in the lung, but this effect is only captured somewhat by the regulatory standard of 24-hour averages. Our research in southern California is vital to the current controversy regarding regulatory standards given that a health-based scientific rationale for any specific PM averaging time is not established.

Conditions

Timeline

Start date
2000-09-01
Completion
2003-10-01
First posted
2001-03-30
Last updated
2006-03-23

Source: ClinicalTrials.gov record NCT00013728. Inclusion in this directory is not an endorsement.